-transparent.png){kind=logo}
The effects of verapamil, a calcium channel blocker, on allyl alcohol (AA) hepatotoxicity were studied in vivo. AA administration induced an increase of serum alanine aminotransferase (ALT) concentration and liver necrosis by means of glutathione (GSH) depletion. Pretreatment with verapamil reduced the increase of ALT in plasma and the morphological signs of necrosis induced by AA administration. Verapamil did not affect GSH levels by itself but prevented the decrease of the tripeptide by AA. In vitro, but not in vivo, verapamil inhibited the activity of alcohol dehydrogenase (ADH), the key enzyme in the conversion of AA into the toxic metabolite acrolein. These data indicate that verapamil protects against AA toxicity, probably by preventing the production of acrolein, its reactive metabolite.
L Atzori, and
L Congiu
January 1981,
Arzneimittel-Forschung,
L Atzori, and
L Congiu
January 1991,
Progress in histochemistry and cytochemistry,
L Atzori, and
L Congiu
August 1978,
Toxicology and applied pharmacology,
L Atzori, and
L Congiu
July 1986,
Acta pharmacologica et toxicologica,
L Atzori, and
L Congiu
January 2001,
Journal of biochemical and molecular toxicology,
L Atzori, and
L Congiu
January 1970,
Acta pharmacologica et toxicologica,
L Atzori, and
L Congiu
January 1985,
Hepatology (Baltimore, Md.),
L Atzori, and
L Congiu
January 1978,
Biochemical Society transactions,
L Atzori, and
L Congiu
May 1997,
Toxicology and applied pharmacology,
L Atzori, and
L Congiu
June 2004,
Journal of toxicology and environmental health. Part A,
